Hi, what are you looking for?
In recent months, illegal immigrant deportations from the United States have emerged as a serious humanitarian and economic problem for Latin America, especially for...
According to World Bank estimates, remittances to low- and middle-income countries reached $685 billion in 2024, up from $647 billion in 2023. With remittances...
It seems as though China’s imports of sanctioned oil are rebounding amid trade tensions with the US. Immediately after Shandong’s shipping ban and the...
The renminbi remained under pressure last week after the US imposed new tariffs on Chinese goods, risking a prolonged trade war. The USD/CNY exchange...
The USD/JPY exchange rate dropped for five consecutive days, reaching a low of 151.42 on Friday, its lowest level since December 11. It has...
The Nikkei 225 index, which includes the biggest Japanese stocks, has remained under pressure this year as the Japanese yen and government bond yields...
MicroStrategy Inc (NASDAQ: MSTR) has already delivered close to 7x returns in the trailing 12 months – but a KBW analyst is convinced it...
Coinbase stock price will be in the spotlight next week as the blue-chip crypto exchange publishes its fourth quarter earnings that will cap its...
Airbnb stock price has price has remained in a tight range in the past three months as concerns about its business remained. It was...
Diversification remains crucial for investors navigating the commodity markets amid geopolitical uncertainties and global trade tensions. As market volatility increases, driven in part by...
The Nikkei 225 index, which includes the biggest Japanese stocks, has remained under pressure this year as the Japanese yen and government bond yields...
MILAN (Reuters) -Italian billionaire Francesco Gaetano Caltagirone has emerged as a leading player in the reshaping of Italy’s financial sector that is currently under...
The first trading day of February saw global equity markets slump as investors reacted to President Trump’s latest tariff threats. These were aimed at...